# The Effect of Oral Administration of 9-cis Rich Powder of the Alga Dunaliella Bardawil on Visual Functions im Patients With Retinitis Pigmentosa

> **NCT01256697** · NA · COMPLETED · sponsor: **Sheba Medical Center** · enrollment: 34 (actual)

## Conditions studied

- Retinitis Pigmentosa

## Interventions

- **DIETARY_SUPPLEMENT:** Alga Dunaliella Bardawil
- **DIETARY_SUPPLEMENT:** Alga Dunaliella Bardawill
- **OTHER:** Sugar pill

## Key facts

- **NCT ID:** NCT01256697
- **Lead sponsor:** Sheba Medical Center
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-08
- **Primary completion:** 2009-04
- **Final completion:** 2011-01
- **Target enrollment:** 34 (ACTUAL)
- **Last updated:** 2013-12-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01256697

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01256697, "The Effect of Oral Administration of 9-cis Rich Powder of the Alga Dunaliella Bardawil on Visual Functions im Patients With Retinitis Pigmentosa". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01256697. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*